CSIMarket


Protalix Biotherapeutics inc   (PLX)
Other Ticker:  
 

Protalix Biotherapeutics inc

PLX's Fundamental analysis








Protalix Biotherapeutics Inc 's sales fell by -60.91 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 1770

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -0.98 %



More on PLX's Growth


Protalix Biotherapeutics Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Protalix Biotherapeutics Inc PEG ratio is at -0.14 Protalix Biotherapeutics Inc realized cash outflow of $ -0.08per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
17.1
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.4.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.65.


More on PLX's Valuation
 
 Total Debt (Millions $) 20
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 10.84
 Tangible Book Value (Per Share $) 0.41

Protalix Biotherapeutics Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Protalix Biotherapeutics Inc PEG ratio is at -0.14 Protalix Biotherapeutics Inc realized cash outflow of $ -0.08per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
17.1
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.4.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.65.

Protalix Biotherapeutics Inc Price to Book Ratio is at 2.8 lower than Indusry Avg. of 751.9. and higher than S&P 500 Avg. of 0.01

More on PLX's Valuation

  Market Capitalization (Millions $) 83
  Shares Outstanding (Millions) 73
  Employees -
  Revenues (TTM) (Millions $) 60
  Net Income (TTM) (Millions $) 7
  Cash Flow (TTM) (Millions $) -6
  Capital Exp. (TTM) (Millions $) -2
  Total Debt (Millions $) 20
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 10.84
  Tangible Book Value (Per Share $) 0.41

  Market Capitalization (Millions $) 83
  Shares Outstanding (Millions) 73
  Employees -
  Revenues (TTM) (Millions $) 60
  Net Income (TTM) (Millions $) 7
  Cash Flow (TTM) (Millions $) -6
  Capital Exp. (TTM) (Millions $) -2





  Ratio
   Capital Ratio (MRQ) 1.38
  Total Debt to Equity (MRQ) 0.69
  Tangible Leverage Ratio (MRQ) 1.86
  Asset Turnover Ratio (TTM) 0.71
  Inventory Turnover Ratio (TTM) 1.09





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com